Guardant Health
GH
#3559
Rank
S$4.02 B
Marketcap
$32.68
Share price
-1.18%
Change (1 day)
-12.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): -$6.73

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$6.40. In 2022 the company made an earnings per share (EPS) of -$8.34 a decrease over its 2021 EPS that were of -$5.21.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.73-19.32%
2022-$8.3460%
2021-$5.2155.04%
2020-$3.36207.14%
2019-$1.09-19.81%
2018-$1.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.28-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.16-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA